Evidence map›Paper›PMID 35877880›Full record

ReviewMembranes2022

Progress for Co-Incorporation of Polydopamine and Nanoparticles for Improving Membranes Performance.

Nada Abounahia, Hazim Qiblawey, Syed Javaid Zaidi

Open access · goldAbstract readReview
In one paragraph

Review in Membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nada AbounahiaDesalination and Water Treatment, Center for Advanced Materials, Qatar University, Doha P.O. Box 2713, Qatar.
Hazim QiblaweyDepartment of Chemical Engineering, College of Engineering, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0003-3485-3354
Syed Javaid ZaidiDesalination and Water Treatment, Center for Advanced Materials, Qatar University, Doha P.O. Box 2713, Qatar.
Qatar University · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Incorporating polydopamine has become a viable method for membrane modification due to its universality and versatility. Fillers in their different categories have been confirmed as effective elements to improve the properties of membranes such as hydrophilicity, permeability, mechanical strength, and fouling resistance. Thus, this paper mainly highlights the recent studies that have been carried out using polydopamine and nanomaterial fillers simultaneously in modifying the performance of different membranes such as ultrafiltration, microfiltration, nanofiltration, reverse osmosis, and forward osmosis membranes according to the various modification methods. Graphene oxide nanoparticles have recently attracted a lot of attention among different nanoparticles used with polydopamine, due to their impressive characteristics impacts on enhancing membrane hydrophilicity, mechanical strength, and fouling resistance. Thus, the incorporation techniques of graphene oxide nanoparticles and polydopamine for enhancing membranes have been highlighted in this work. Moreover, different studies carried out on using polydopamine as a nanofiller for optimizing membrane performance have been discussed. Finally, perspectives, and possible paths of further research on mussel-inspired polydopamine and nanoparticles co-incorporation are stated according to the progress made in this field. It is anticipated that this review would provide benefits for the scientific community in designing a new generation of polymeric membranes for the treatment of different feed water and wastewater based on adhesive mussel inspired polydopamine polymer and nanomaterials combinations.

Indexed as

dopaminemembranesmussel-inspired chemistrynanoparticlespolydopamine

Identifiers

PMID35877880
PMCPMC9317275
OpenAlexW4283756411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.